What does the research say about tendon healing?
Tendon healing research spans surgical adjuncts, peptides, and metabolic agents. This page summarises the registered trials and preclinical models, and states plainly where the evidence is animal-only or in vitro.
What does the research say about tendon healing?
Tendon healing is the biological process by which a damaged tendon restores continuity and load-bearing capacity. In the research literature it is studied under several names, including tendon repair, tendon-to-bone healing (enthesis healing), and tendinopathy resolution, depending on whether the injury is acute or chronic. The tissue class is dense regular connective tissue, dominated by type I collagen arranged in parallel fascicles with a sparse resident cell population (tenocytes) and limited intrinsic vascularity. The identifiers that recur across the evidence below are surgical models (arthroscopic rotator cuff repair, aRCR; single-row repair; Achilles tendon transection), outcome instruments (Constant-Murley score, CMS), and molecular agents (BPC-157, TB-500, BMP-7, bFGF, VEGFA, GHRP-2, metformin, sex hormones).
The pathway families that the work centres on are growth factor receptor signalling (fibroblast growth factor receptor, vascular endothelial growth factor receptor, bone morphogenetic protein receptor) and macrophage polarisation, with the M1/M2 balance acting as a recurring upstream control point on reparative cell recruitment.
Research Studies
BPC-157 and tendon healing after arthroscopic rotator cuff repair in humans
A randomised, double-blind, placebo-controlled pilot trial is investigating BPC-157 for tendon healing and functional recovery following arthroscopic rotator cuff repair. Twenty patients undergoing aRCR are to be randomly assigned to BPC-157 or saline placebo, with daily subcutaneous self-administration for 90 days after surgery, alongside standard postoperative care. The record notes that BPC-157 is a synthetic peptide with regenerative and anti-inflammatory effects reported in preclinical animal models of musculoskeletal injury, and that it had not yet been studied in formal human clinical trials [1].
BPC-157 and TB-500 in a rat Achilles tendon healing model
In a rat model, BPC-157, synthetic thymosin beta-4 (TB-500), and their combination were evaluated for Achilles tendon healing using biomechanical, histopathological, histochemical, and immunohistochemical analyses. Thirty-two male Sprague-Dawley animals were used [6]. This is animal evidence; it does not establish human outcomes.
Autologous microfragmented lipoaspirate tissue and long-term outcome after rotator cuff repair
A prospective randomised controlled single-blind trial evaluated autologous microfragmented lipoaspirate tissue in arthroscopic rotator cuff repair. The hypothesis tested was that an intraoperative injection of autologous microfragmented adipose tissue, processed with an enzyme-free technology, could improve clinical outcomes of single-row arthroscopic rotator cuff repair as measured by Constant-Murley score at least 5 years after surgery [2].
Metformin and chronic Achilles tendon pain in non-diabetic patients
An exploratory clinical trial is assessing oral metformin in non-diabetic patients with chronic Achilles tendon pain. It has two aims: to assess effects on tendon pain, and to determine effects of metformin capsules on tendon healing and repair. Twenty participants are to receive metformin capsules for 16 weeks combined with a home exercise programme, and a comparison group of 20 participants is to receive placebo tablets with the same exercise programme [3].
Sex hormone supplementation and rotator cuff repair in men with low hormone levels
A pilot study is randomising men with low sex hormone levels to sex hormone therapy or placebo pills while healing from shoulder tendon repair surgery. The investigators state that repaired tendon often does not heal after surgery, and that they will test whether increased sex hormone levels show promise for tendon healing, shoulder function, and pain [4].
Spatially distributed bFGF and VEGFA gene delivery to tendon and peritendinous tissues
Work on gene delivery reports that tendon healing is limited by inadequate vascularity and low cellularity within the tendon, while surrounding peritendinous tissues contain vascular, stromal, and extrinsic reparative cells. Building on prior tendon-only co-delivery of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor A (VEGFA), the approach examined spatially distributed delivery to tendon and peritendinous tissues and reported enhancement of early tendon healing [5].
BMP-7 and low-molecular-weight peptide solution in a rat rotator cuff tear model
Because rotator cuff tears are the most prevalent shoulder pathology requiring surgery and retear rates remain high, a rat study evaluated bone morphogenetic protein-7 (BMP-7) and a low-molecular-weight peptide solution (LMWPS) for early tendon-to-bone healing using histopathological and biomechanical methods [7]. This is animal evidence.
GHRP-2 and macrophage polarisation in a rat rotator cuff tear model
Growth hormone-releasing peptide 2 (GHRP-2) was explored for tendon-bone healing in a rat rotator cuff tear model. The effect of GHRP-2 on M1 macrophage polarisation was determined in vitro by real-time polymerase chain reaction, Western blot, and immunofluorescence, and the work reported an association with decreased M1 macrophage production together with increased histological and biomechanical tendon-bone healing properties [8]. The in vitro component is cell-based; the healing findings are from animals.
Comparison of agents and evidence stage
| Agent or intervention | Model or population | Evidence stage | Source |
|---|---|---|---|
| BPC-157 | Humans undergoing arthroscopic rotator cuff repair | Registered randomised pilot trial | [1] |
| BPC-157, TB-500, combination | Rat Achilles tendon | Preclinical (animal) | [6] |
| Autologous microfragmented lipoaspirate tissue | Humans, single-row rotator cuff repair | Randomised single-blind trial, 5-year CMS | [2] |
| Metformin (oral) | Non-diabetic humans with chronic Achilles tendon pain | Exploratory randomised trial | [3] |
| Sex hormone therapy | Men with low sex hormone levels after shoulder tendon repair | Pilot randomised trial | [4] |
| bFGF and VEGFA gene delivery | Tendon and peritendinous tissues | Preclinical | [5] |
| BMP-7 and LMWPS | Rat rotator cuff tear | Preclinical (animal) | [7] |
| GHRP-2 | Rat rotator cuff tear; in vitro macrophage assays | Preclinical (animal and cell-based) | [8] |
If you are reading this for personal health reasons
The materials described on this page are sold for laboratory research use only. We do not provide dosing information or medical guidance, and nothing here should be taken as a recommendation for use in a person. Anyone considering a compound for their own health should speak to a licensed clinician.
Sources
- [1] Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery — https://clinicaltrials.gov/study/NCT07803250
- [2] Long Term Clinical Outcome After Arthroscopic Rotator Cuff Repair Augmentation With Autologous Microfragmented Lipoaspirate Tissue — https://clinicaltrials.gov/study/NCT06960343
- [3] Managing Chronic Tendon Pain by Metformin — https://clinicaltrials.gov/study/NCT06100822
- [4] Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial — https://clinicaltrials.gov/study/NCT04944836
- [5] Spatially distributed bFGF and VEGFA gene delivery to tendon and peritendinous tissues enhances early tendon healing — https://pubmed.ncbi.nlm.nih.gov/42704563/
- [6] Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study — https://pubmed.ncbi.nlm.nih.gov/42542926/
- [7] Effects of bone morphogenetic protein-7 and low-molecular-weight peptide solution on healing in a rotator cuff tear model: a histopathologic and biomechanical study in rats — https://pubmed.ncbi.nlm.nih.gov/41967630/
- [8] Growth Hormone-Releasing Peptide 2 May Be Associated With Decreased M1 Macrophage Production and Increased Histologic and Biomechanical Tendon-Bone Healing Properties in a Rat Rotator Cuff Tear Model — https://pubmed.ncbi.nlm.nih.gov/39672241/